KLDO News and Press, Kaleido Biosciences Inc. From 05/04/21

Kaleido Biosciences (KLDO): Q1 GAAP EPS of -$0.58 misses by $0.01.As of March 31, 2021, the Company reported cash and cash equivalents of $92.4 million. The Company continues to manage its operating expenses and, as a result, has cash runway into the first quarter of 2022.Press Release For ...

--Positive results in patients with mild-to-moderate COVID-19 demonstrate KB109’s potential to reduce healthcare utilization and recovery time; initiating IND application to support further development-- --Topline data from a clinical study of KB295 in patients with mild-to...

Gainers: Takung Art (TKAT) +33%.Teradata (TDC) +29%.Renalytix AI (RNLX) +24%.Qualtrics International (XM) +24%.Galectin Therapeutics (GALT) +23%.Kaleido Biosciences (KLDO) +21%.CEL-SCI (CVM) +21%.Novan (NOVN) +20%.Nikola (NKLA) +17%.Equifax (EFX) +17%.Losers: Evolus (EOLS) ...

LEXINGTON, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a small molecule driven approach to targeting the microbiome to treat disease and improve human health, today announced a research collaboration wi...

Gainers: [[ANPC]] +32.0%. [[KLDO]] +3.4%. [[EBON]] +3.3%. [[VYGR]] +3.1%. [[RAIL]] +2.6%.Losers: [[CGEN]] -2.7%. [[RXRX]] -2.6%. [[CLPS]] -2.3%. [[LIZI]] -2.1%. [[VSTM]] -1.9%. For further details see: ANPC, KLDO, CGEN and CLPS among after-hours movers

Gainers: Wilhelmina International (WHLM) +25%.Kaleido Biosciences (KLDO) +14%.Ardelyx (ARDX) +14%.PLBY Group (PLBY) +14%.Talis Biomedical (TLIS) +14%.Wah Fu Education (WAFU) +12%.Seelos Therapeutics (SEEL) +11%Inpixon (INPX) +11%.BCTG Acquisition (BCTG) +10%.Ballantyne Strong (...

Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer PR Newswire CAMBRIDGE, Mass. , March 30, 2021 /PRNewswire/ -- Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the pot...

Hall of Fame Resort & Entertainment Company (HOFV) +71% after NFT deal.Dolphin Entertainment (DLPN) +66% after NFT deal.Alithya Group (ALYA) +52% on acquisition of R3D ConseilColor Star Technology (CSCW) +41%.Aptose Biosciences (APTO) +39% on Q4 results.Cinedigm C...

Kaleido Biosciences (KLDO) reports positive results from a non-IND study of KB109 in patients with mild-to-moderate COVID-19.KB109 demonstrated an overall favorable safety and tolerability profile with no treatment-related adverse events.Healthcare utilization, as measured by the total number...

KB109 demonstrated favorable safety and tolerability profile Kaleido intends to file an Investigational New Drug (IND) application, with the goal of advancing KB109 directly into a pivotal registration program Company to host conference call today at 8:30am ET ...